Het traditionele business model van de big pharma werkt allang niet meer. Janssen Pharmaceutica zoekt dan ook naar succesvolle formules om te innoveren. Eén van de innovatietrajecten dat alvast veelbelovend is, is Serious Gaming. Tom Aelbrecht, directeur van het incubatiecentrum van het Venture & Incubationcenter van Janssen, neemt ons mee doorheen het innovatietraject en laat ons zien waarom zij misschien zelfs meer geloven in de toekomst van games dan die van pillen.

1. Medicines & Games
Janssen Pharmaceutica NV
Tom Aelbrecht
Director Venture & Incubation Center

2. Today it is estimated that Alzheimer's disease affects about 26 million people
worldwide. With an increasing aged population, that number is expected to be four
times that of today by 2050.
(Source: Alzheimer Europe)
Janssen Proprietary & Confidential 2

3. In 2007, 33.2 million people were estimated to be living with HIV/AIDS, 2.5
million people became newly infected and 2.1 million people died of HIV/AIDS.
(Source: World Health Organization)
Janssen Proprietary & Confidential 3

4. Cancer in Europe affects 1 in 3 men and 1 in 4 women at some time in their lives. It
is estimated that 1,2 million EU citizens die from cancer each year which kills
about one in four people in Europe.
(Source: Public Health Portal of the European Union)
Janssen Proprietary & Confidential 4

5. There are approximately 170 million people chronically infected with hepatitis
C worldwide.
Janssen Proprietary & Confidential 5

6. Each year Cardiovascular Disease (CVD) causes over 4.3 million deaths in
Europe. Overall CVD is estimated to cost the EU economy
€192 billion a year.
(Source: European Heart Network)
Janssen Proprietary & Confidential 6

7. Diabetes currently affects 246 million people worlwide and is expected to affect 380
million by 2025. Each year 3.8 million deaths are attributable to diabetes.
(Source: International Diabetes Foundation)
Janssen Proprietary & Confidential 7

8. Caring for the world, one person
at a time…
… inspires and unites the people
of Johnson & Johnson.
Janssen Proprietary & Confidential 8

9. We embrace research and science
− bringing innovative ideas,
products and services to advance
the health and well-being of
people.
Janssen Proprietary & Confidential 9

10. Quiz
What’s the average time required to
develop a medicine?
What’s the average cost associated with
developing a drug?
How’s the pharmaceutical industry rated
in the overall industry image poll?
Janssen Proprietary & Confidential 10

11. A new era of healthcare
Towards sustainable
integrated
consumer centric
healthcare solutions
Need for:
New Healthcare models
What do we offer as solution?
New Collaboration models
How do we get there
and with whom?
New Business models
How do we create value for
every one?
FUTURE MODEL
Janssen Proprietary & Confidential 11

12. Our mission and vision
We are driven by the care for our
patients – our goal is to create,
develop and deliver ground-
breaking therapeutic solutions
that will make a difference.
Therefore, we build an open
entrepreneurial community in
which we, as a center of
innovation, focus together on
activities with a high added value.
Janssen Proprietary & Confidential 12

13. Approach – Incubation & Acceleration
Janssen Proprietary & Confidential 16/12/2011 13

14. HealSeeker
Serious gaming for children with ADHD

15. Janssen Proprietary & Confidential 11/02/2013 15

16. HealSeeker
A Serious Game developed by
domain specialists for children
with ADHD to train on
time management,
planning & organization
social behaviour
Janssen Proprietary & Confidential
11/02/201 16
3

17. Our ambition
Validate and launch
a serious game in 2013 which will improve people’s live
Janssen Proprietary & Confidential 11/02/2013 17

18. Who to contact?
janssencampusbe@its.jnj.com
+32 14 60 31 89
Janssen Proprietary & Confidential 18